CVS Health CorporationCVSNYSE
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+9.0%
5Y CAGR+9.6%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+9.0%/yr
vs +13.2%/yr prior
5Y CAGR
+9.6%/yr
Consistent
Acceleration
-4.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
9 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $346.70B | +7.9% |
| 2024 | $321.41B | +6.0% |
| 2023 | $303.35B | +13.2% |
| 2022 | $267.96B | +11.7% |
| 2021 | $239.99B | +9.3% |
| 2020 | $219.66B | +4.0% |
| 2019 | $211.25B | +29.6% |
| 2018 | $163.04B | +4.3% |
| 2017 | $156.26B | +5.1% |
| 2016 | $148.71B | - |